Ajanta Pharma has reported results for second quarter ended September 30, 2014.
The company has registered 40.89% rise in its net profit at Rs 78.63 crore for the quarter under review as compared to Rs 55.81 crore for the same quarter in the previous year. Total income from operations of the company has increased 23.44% at Rs 353.20 crore for Q2FY15 as compared Rs 286.13 crore for the corresponding quarter previous year.
Ajanta Pharma is engaged in manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales.
